Navigation Links
Neurocrine Biosciences Secures Committed Equity Financing Facility
Date:9/15/2009

subject to certain conditions, including a minimum share price threshold and the requirement that no individual tranche exceed $15 million. Kingsbridge may purchase shares of common stock pursuant to the CEFF at discounts ranging from 5 to 10 percent, depending on the average market price of Neurocrine's common stock during the applicable pricing period.

The CEFF does not impose any restrictions on Neurocrine's operating activities or capital raising alternatives, other than with respect to financings similar to the CEFF. During the term of the CEFF, Kingsbridge is prohibited from engaging in any short selling or derivative transactions related to Neurocrine's common stock.

The securities issuable pursuant to the CEFF have not been registered under the Securities Act of 1933 and may not be offered or sold in the United States absent registration under the Securities Act of 1933 and applicable state securities laws or available exemptions from registration requirements. Neurocrine has agreed to file a registration statement with respect to the resale of shares issued pursuant to the CEFF within 60 days of the date of the CEFF agreement.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state. Any offering of Neurocrine's common stock under the registration statement referred to above will be made only by means of a prospectus.

Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on neurological and endocrine diseases and disorders. Our product candidates address some of the largest pharmaceutical markets in the world including endometriosis, anxiety, depression, pain, diabetes, benign prostatic hyperplasia (BPH), irri
'/>"/>

SOURCE Neurocrine Biosciences, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Neurocrine Biosciences to Present at the BioCentury: Newsmakers in the Biotech Industry Conference
2. Neurocrine Biosciences to Present at the Thomas Weisel Partners Healthcare Conference
3. Neurocrine Biosciences to Present at the Bear Stearns Healthcare Conference
4. Neurocrine Biosciences to Present at the A.G. Edwards Annual Emerging Growth Conference
5. Neurocrine Biosciences to Present at the UBS Global Life Sciences Conference
6. Neurocrine Biosciences Announces Conference Call and Webcast to Present Third Quarter 2007 Financial Results
7. Neurocrine Biosciences and Dainippon Sumitomo Pharma (DSP) Announce Agreement to Develop and Commercialize Indiplon in Japan
8. Neurocrine Biosciences Announces Conference Call and Webcast to Provide Indiplon Update
9. Neurocrine Receives Approvable Letter for Indiplon Capsules with Additional Safety and Efficacy Data Required by FDA
10. Neurocrine Announces Work Force Restructuring
11. Neurocrine Announces Appointment of Kevin Gorman, Ph.D., as President and Chief Executive Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... June 19, 2013 ... presents Innovative Drug Delivery Systems: ... Licensing Opportunities for Generic Pharmaceutical ... There are more than ... drugs approved all over the ...
(Date:6/19/2013)... Applied Rigaku Technologies, Inc. is pleased to ... of sulfur in ultra-low sulfur diesel (ULSD) using the ... analyzer . The analysis detailed in Rigaku Application Note ... This International Standard specifies an energy dispersive X-ray fluorescence ... in automotive gasoline. , Regulations around the world have ...
(Date:6/19/2013)... Adding to their already extensive supply of ... Dropette® and Heathrow Scientific disposable plastic transfer ... biology, chemistry and any type of liquid handling analysis ... years, Simport has been supplying the science community with ... Simport Dropette®. Simport’s Dropette® is a one-piece plastic ...
(Date:6/18/2013)... KONG, June 18, 2013 China Cord Blood ... "Company"), China,s leading provider of cord blood collection, laboratory ... services, today announced its preliminary unaudited financial results for ... 2013 ended March 31, 2013. Fourth ... the fourth quarter of fiscal 2013 increased by 33.3% ...
Breaking Biology Technology:Innovative Drug Delivery Systems: Novel Product and Formulation Technology Licensing Opportunities for Generic Pharmaceutical Companies 2Innovative Drug Delivery Systems: Novel Product and Formulation Technology Licensing Opportunities for Generic Pharmaceutical Companies 3Rigaku Publishes New Application Note for Analysis of ULSD Per ISO 13032 2Leading Pipette Distributor Pipette.com Now Stocks Transfer Pipettes: Simport’s Dropette and Heathrow Scientific Disposable Plastic Transfer Pipettes 2China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 2China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 3China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 4China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 5China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 6China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 7China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 8China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 9China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 10China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 11China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 12China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 13
... Life Sciences Industry in ... Western ... (PLSG), the organization providing capital investments and,customized company formation and ... the PLSG has reached a,significant milestone with over $10 million ...
... (Amex: ILI ), today announced that it ... Financial Officer., Lewis H. Bender, Chief Executive ... "Eliot is an innovative and experienced,senior financial executive ... achievement in managing growth for publicly traded companies. ...
... 19.1% ... Improving Full Year Outlook, ORANGE COUNTY, Calif., April 30 ... that simplify,automate and innovate biomedical testing, today announced first quarter,ended March ... quarter 2007. In constant currency, revenue rose 14.5%. Net,earnings grew 15.6% ...
Cached Biology Technology:The Pittsburgh Life Sciences Greenhouse Tops $10M in Company Investments 2The Pittsburgh Life Sciences Greenhouse Tops $10M in Company Investments 3Interleukin Genetics Appoints Eliot M. Lurier Chief Financial Officer 2Interleukin Genetics Appoints Eliot M. Lurier Chief Financial Officer 3Beckman Coulter Announces First Quarter 2008 Results 2Beckman Coulter Announces First Quarter 2008 Results 3Beckman Coulter Announces First Quarter 2008 Results 4Beckman Coulter Announces First Quarter 2008 Results 5Beckman Coulter Announces First Quarter 2008 Results 6Beckman Coulter Announces First Quarter 2008 Results 7Beckman Coulter Announces First Quarter 2008 Results 8Beckman Coulter Announces First Quarter 2008 Results 9Beckman Coulter Announces First Quarter 2008 Results 10Beckman Coulter Announces First Quarter 2008 Results 11Beckman Coulter Announces First Quarter 2008 Results 12Beckman Coulter Announces First Quarter 2008 Results 13Beckman Coulter Announces First Quarter 2008 Results 14Beckman Coulter Announces First Quarter 2008 Results 15Beckman Coulter Announces First Quarter 2008 Results 16Beckman Coulter Announces First Quarter 2008 Results 17Beckman Coulter Announces First Quarter 2008 Results 18Beckman Coulter Announces First Quarter 2008 Results 19Beckman Coulter Announces First Quarter 2008 Results 20Beckman Coulter Announces First Quarter 2008 Results 21Beckman Coulter Announces First Quarter 2008 Results 22Beckman Coulter Announces First Quarter 2008 Results 23
(Date:6/19/2013)... study of the patients who received injections of ... the New England Compounding Center has found that ... did not experience a worsening of their symptoms ... detect infection, especially among those individuals who received ... study, along with an editorial by UC Davis ...
(Date:6/19/2013)... 2013 - The Flemish plant scientist Marc Van Montagu ... 2013", jointly with the American scientists Mary-Dell Chilton and ... on Wednesday by the US Secretary of State, John ... for food and agriculture" - gives the award annually ... of exceptional social importance for the quality, quantity or ...
(Date:6/19/2013)... of researchers at the University of Pittsburgh has ... of HIV, that could be potential treatments for ... resistance. These new agents are quite small, making ... was published in the June 2013 issue of ... , The first of many probable applications will ...
Breaking Biology News(10 mins):Evolution of an outbreak: Complications from contaminated steroid injections 2World Food Prize goes to a Belgian for the first time: The scientist Marc Van Montagu 2World Food Prize goes to a Belgian for the first time: The scientist Marc Van Montagu 3World Food Prize goes to a Belgian for the first time: The scientist Marc Van Montagu 4HIV-derived antibacterial shows promise against drug-resistant bacteria 2
... Sonic hedgehog, a gene that plays a crucial rule in the ... in an unexpected place in the embryos of developing mice ... a video game character, Sonic hedgehog describes both a gene and ... to increase understanding of human birth defects. It was thought ...
... associate professor at the Courant Institute of Mathematical Sciences, ... Waterman Award, which is given annually to an outstanding ... supported by NSF. The honor includes a grant of ... study in any field of science. Khot is ...
... , This press release is available in ... for Chemical Ecology in Jena have investigated another navigational skill ... remarkable visual orientation: they use a sun compass along with ... after foraging for food. After the research team from Jena ...
Cached Biology News:Sonic hedgehog gene found in an unexpected place during limb development 2Sonic hedgehog gene found in an unexpected place during limb development 3NYU Courant professor wins NSF's Waterman Award 2Smelling the scenery in stereo 2
... designed for two-dimensional electrophoresis (2D) and ... in this marker have been selected ... a 2D gel. The pI range ... Mol wt: 17,000-89,000 Physical Form: ...
... The M-840 HEXALIGHT robot is based on ... (PKM) over more than a decade. PI ... for mirror and antenna adjustments over wide ... provides six degrees of freedom with 3 ...
... offers a full length insert sequencing service ... cosmids and fosmids. Agencourt utilizes unique ... libraries. There are several features that ... data with rapid turnaround including our patented ...
... On-Demand Cytometry The Guava EasyCyte system ... based multiparameter cytometer with built-in 96-well microplate ... screen plates of cells and compounds quickly ... multiple tubes or having the carryover issues ...
Biology Products: